INOZYME PHARMA

Lobbying client · Massachusetts · filed 2025 to 2025

Treatments for PPi-Adenosine Pathway, ENPP1 Deficiency, ABCC6 Deficiency, & calciphylaxis.

$20,000 Reported spend

3 Filings counted

1 Firms hired

7 Bills named

Spend is reported income plus in-house expenses across 3 filings. Everything on this page is grouped by the client's LDA id (67750), not by name.

Firms hired 1

THE KPM GROUP DC LLC $20,000 3 filings

Bills named in these filings 7

HR 1262
Mikaela Naylon Give Kids a Chance Act

2 filings
HR 1414
Cameron’s Law

2 filings
HR 1492
To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and bi…

2 filings
HR 1532
Scientific EXPERT Act of 2025

2 filings
HR 946
ORPHAN Cures Act

2 filings
S 822
Scientific EXPERT Act of 2025

1 filing
S 932
Give Kids a Chance Act of 2025

1 filing

Reported by year 1 year

2025 $20,000 3 filings

Issues lobbied 1

Pharmacy 2

The count is how many filings named that issue area. A filing reports one lump figure covering every issue on it, so the money above cannot be split between them.

Agencies and chambers lobbied 2

HOUSE OF REPRESENTATIVES 1
SENATE 1

Recent filings 3 total

3TY

THE KPM GROUP DC LLC

3rd Quarter (July 1 - Sep 30) 2025 · posted Oct 17, 2025

View → Q2

THE KPM GROUP DC LLC

2nd Quarter (Apr 1 - June 30) 2025 · House · Senate · $20,000 income · posted Jul 17, 2025

View → RR

THE KPM GROUP DC LLC

2nd Quarter (Apr 1 - June 30) 2025 · posted Jul 15, 2025

View →

Source: federal Lobbying Disclosure Act filings, synced daily. Money is self-reported by the filer and often rounded. Lobbying is legal, disclosed activity.